| Particulars |
|
|
|
| Company Name
| Shukra Pharmaceuticals Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
43.79 |
B.V. (₹) |
1.20 |
| Sales(₹ Cr.) |
74.57 |
NP (₹ Cr.) |
18.54 |
| NP Var% |
321.00 |
Div% |
10.00 |
| CPS(₹) |
0.50 |
EPS (₹) |
0.40 |
| Traded Value(₹ Lakhs) |
170.42 |
52 Week High |
27.00 |
| 52 Week Low |
6.00 |
Price BSE |
21.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
898.53 |
| P/C Ratio |
44.70 |
P/E Ratio |
49.60 |
| Price Vs.BV |
17.50 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
10.58 |
| NP(₹ Cr.) |
3.16 |
NP Var % |
-66.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
38.51 |
| OPM |
40.12 |
NP |
14.43 |
| NP Var% |
-55.88 |
EPS |
0.19 |
| PE |
108.00 |
|
|